Redhawk Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Redhawk Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-411	Closed	-$205K	–	352
2025 Q1	$205K	Buy	+411	New	+$223K	0.03%	286
2024 Q4	–	Sell	-352	Closed	-$218K	–	328
2024 Q3	$218K	Buy	+352	New	+$208K	0.03%	290
2023 Q4	–	Sell	-406	Closed	-$205K	–	314
2023 Q3	$205K	Buy	+406	New	+$216K	0.07%	191
2022 Q1	–	Sell	-813	Closed	-$542K	–	267
2021 Q4	$542K	Buy	813 +29	+4%	+$18.1K	0.14%	103
2021 Q3	$448K	Buy	784 +186	+31%	+$102K	0.12%	119
2021 Q2	$302K	Sell	598 -30	-5%	-$14.2K	0.07%	187
2021 Q1	$286K	Sell	628 -18	-3%	-$8.59K	0.07%	179
2020 Q4	$301K	Sell	646 -29	-4%	-$13.6K	0.08%	181
2020 Q3	$298K	Buy	675 +34	+5%	+$14K	0.09%	166
2020 Q2	$232K	Buy	+641	New	+$215K	0.08%	165
2019 Q3	–	Sell	-106	Closed	-$31K	–	404
2019 Q2	$31K	Buy	+106	New	+$29.2K	0.01%	287

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Redhawk Wealth Advisors's TMO Position: Q2 2025 in Review

Redhawk Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 411 shares — an estimated $205K sold.

Redhawk Wealth Advisors first reported a position in TMO in Q2 2019 and held it in 11 quarters. The position peaked at $542K in Q4 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Redhawk Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Redhawk Wealth Advisors sold 411 Thermo Fisher Scientific shares in Q2 2025, an estimated $205K.
Redhawk Wealth Advisors first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 11 quarters.
Redhawk Wealth Advisors's Thermo Fisher Scientific position peaked at $542K in Q4 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2025, filed 10 Jul 2025.